Research Roundup

Debbie Rigby rounds up the latest in research news SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? Based on currently available data and in view of the overwhelming evidence of mortality reduction in cardiovascular disease, ACE-I and ARB therapy should be maintained or initiated in patients with heart failure, hypertension,